Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

11.78
Delayed Data
As of Mar 27
 +0.46 / +4.06%
Today’s Change
7.09
Today|||52-Week Range
12.11
+41.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues9.1M29.7M52.5M30.8M
 
 
 
 
 
Cost of Goods Sold267.0K1.4M1.1M2.3M
 
 
 
 
 
Depreciation And Amortization227.0K233.0K241.0K--
 
 
 
 
 
Operating ExpensesGross Income8.6M28.0M51.2M28.5M
 
 
 
 
 
General Expenses22.0M24.3M22.0M23.8M
 
 
 
 
 
Research And Development4.5M4.7M4.7M5.8M
 
 
 
 
 
Total Operating Expenses22.5M25.9M23.3M26.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.4M3.8M29.2M4.7M
 
 
 
 
 
Extraordinary Credit677.0K678.0K760.0K694.0K
 
 
 
 
 
Extraordinary Charge-1.7M-39.0K-860.0K0.00
 
 
 
 
Interest Expense On Debt1.2M1.3M1.3M1.2M
 
 
 
 
 
Other Expenses0.000.002.0K120.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.5M3.2M27.9M4.4M
 
 
 
 
 
Net Income-15.5M3.2M27.9M4.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.1M42.1M42.9M42.9M
 
 
 
 
 
Shares To Calculate EPS Diluted41.1M42.4M50.8M43.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.38$0.08$0.39$0.10
 
 
 
 
 
EPS Diluted-$0.38$0.08$0.39$0.10
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account